Alpha Tau Medical Ltd.
DRTS
$2.61
-$0.03-1.14%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | -- | -- | 9.26M | 9.41M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 35.68M | 33.72M | |
| Operating Income | -- | -- | -35.68M | -33.72M | |
| Income Before Tax | -- | -- | -29.14M | -25.18M | |
| Income Tax Expenses | -- | -- | 16.00K | 11.00K | |
| Earnings from Continuing Operations | -- | -- | -29.16 | -25.19 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -29.16M | -25.19M | |
| EBIT | -- | -- | -35.68M | -33.72M | |
| EBITDA | -- | -- | -34.67M | -32.73M | |
| EPS Basic | -- | -- | -0.42 | -0.36 | |
| Normalized Basic EPS | -- | -- | -0.14 | -0.11 | |
| EPS Diluted | -- | -- | -0.42 | -0.36 | |
| Normalized Diluted EPS | -- | -- | -0.14 | -0.11 | |
| Average Basic Shares Outstanding | -- | -- | 277.51M | 277.12M | |
| Average Diluted Shares Outstanding | -- | -- | 277.51M | 277.12M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |